Facilitated By

San Antonio Medical Foundation

A Phase 2/3, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study To Evaluate The Safety And Efficacy Of 2 Regimens Of Orally Administered PF-07321332/RITONAVIR In Preventing Symptomatic SARS-COV-2 Infection In Adult Household Contacts Of An Individual With Symptomatic COVID-19

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Research Start Date

Primary objective of this study is to evaluate the effectiveness using ritonavirin in preventing SARS-CoV-2 infection.

Collaborative Project
Clinical Care
Infectious Disease
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.